5 research outputs found
Direct determination of urinary creatinine by reactive-thermal desorption-extractive electrospray-ion mobility-tandem mass spectrometry.
A direct, ambient ionization method has been developed for the determination of creatinine in urine that combines derivatization and thermal desorption with extractive electrospray ionization and ion mobility-mass spectrometry. The volatility of creatinine was enhanced by a rapid on-probe aqueous acylation reaction, using a custom-made thermal desorption probe, allowing thermal desorption and ionization of the monoacylated derivative. The monoacyl creatinine [M + H] ion (m/z 156) was subjected to mass-to-charge selection and collision induced dissociation to remove the acyl group, generating the protonated creatinine [M + H] product ion at m/z 114 before an ion mobility separation was applied to reduce chemical noise. Stable isotope dilution using creatinine-d as internal standard was used for quantitative measurements. The direct on-probe derivatization allows high sample throughput with a typical cycle time of 1 min per sample. The method shows good linearity (R = 0.986) and repeatability (%RSD 8-10%) in the range of 0.25-2.0 mg/mL. The creatinine concentrations in diluted urine samples from a healthy individual were determined to contain a mean concentration of 1.44 mg/mL creatinine with a precision (%RSD) of 9.9%. The reactive ambient ionization approach demonstrated here has potential for the determination of involatile analytes in urine and other biofluids. © 2013 American Chemical Society
Determination of free desmosine and isodesmosine as urinary biomarkers of lung disorder by ultra performance liquid chromatography-ion mobility-mass spectrometry
The elastin degradation products, desmosine (DES) and isodesmosine (IDES) are highly
stable, cross-linking amino-acids that are unique to mature elastin. The excretion of
DES/IDES in urine, in the free form and with associated peptide fragments, provides an
indicator of lung damage in chronic obstructive pulmonary disease (COPD). A quantitative
ion mobility-mass spectrometry (IM-MS) method has been developed for the analysis of free
DES/IDES in urine with deuterated IDES as an internal standard.
Resolution of DES/IDES isomers was achieved in less than five minutes using ultra
performance liquid chromatography (UPLC) combined with ion pairing. The optimized
UPLC-IM-MS method provided a linear dynamic range of 10-300 ng/mL and a limit of
quantitation of 0.028 ng/mL for IDES and 0.03 ng/mL for DES (0.55 ng and 0.61 ng on
column respectively). The method reproducibility (%RSD) was < 4% for DES and IDES.
The UPLC-IM-MS method was applied to the analysis of urine samples obtained from
healthy volunteers and COPD patients. The DES/IDES concentrations in healthy and
COPD urine showed an increase in DES (79%) and IDES (74%) in the COPD samples,
relative to healthy controls. The incorporation of an IM separation prior to m/z measurement
by MS was shown to reduce non-target ion responses from the bio-fluid matrix
Direct extraction of urinary analytes from undeveloped reversed-phase thin layer chromatography plates using a solvent gradient combined with on-line electrospray ionisation ion mobility-mass spectrometry
The direct extraction of urinary analytes deposited on reversed-phase thin-layer chromatography (RP-TLC) plates is demonstrated using a solvent gradient extraction procedure without prior chromatographic development. The surface sample probe TLC-MS interface used for the gradient extraction is compared to direct loop injection into the electrospray ion source for biofluid profiling. The gradient elution is shown to enhance ion intensities, as urinary salts are eluted in aqueous formic acid in the early part of the gradient reducing ion suppression. The retention of urinary components on the C18 RP-TLC plate was confirmed by monitoring analyte responses with, and without, an aqueous wash phase prior to the solvent gradient extraction. The use of gradient elution allows fractionation of the complex biological matrix as a result of differential retention of urine components on the undeveloped RP-TLC plate. The direct gradient analysis of TLC plates has also been combined with ion mobility-mass spectrometry to further resolve the complex urinary profile and identify co-eluting compounds
Direct detection of a sulfonate ester genotoxic impurity by atmospheric-pressure thermal desorption−extractive electrospray−mass spectrometry
A direct, ambient ionization method has been developed using atmospheric pressure thermal desorption−extractive electrospray−mass spectrometry (AP/TD-EESI-MS) for the detection of the genotoxic impurity (GTI) methyl p-toluenesulfonate (MTS) in a surrogate pharmaceutical matrix. A custom-made thermal desorption probe was used to the desorb and vaporize MTS from the solid state, by rapid heating to 200 °C then cooling to ambient temperature, with a cycle time of 6 min. The detection of MTS using EESI with a sodium acetate doped solvent to generate the [MTS+Na]+ adduct ion provided a significant sensitivity enhancement relative to the [M+H]+ ion generated using a 0.1% formic acid solvent modifier. The MTS detection limit is over an order of magnitude below the longterm daily threshold of toxicological concern (TTC) of 1.5 μg/g and the potential for quantitative analysis has been determined using starch as a surrogate active pharmaceutical ingredient (API)
Enhanced analyte detection using in-source fragmentation of field asymmetric waveform ion mobility spectrometry-selected ions in combination with time-of-flight mass spectrometry
Miniaturized ultra high field asymmetric waveform
ion mobility spectrometry (FAIMS) is used for the
selective transmission of differential mobility-selected ions
prior to in-source collision-induced dissociation (CID) and
time-of-flight mass spectrometry (TOFMS) analysis. The
FAIMS-in-source collision induced dissociation-TOFMS
(FISCID-MS) method requires only minor modification of
the ion source region of the mass spectrometer and is shown
to significantly enhance analyte detection in complex mixtures.
Improved mass measurement accuracy and simplified product
ion mass spectra were observed following FAIMS preselection and subsequent in-source CID of ions derived from
pharmaceutical excipients, sufficiently close in m/z (17.7 ppm mass difference) that they could not be resolved by TOFMS alone.
The FISCID-MS approach is also demonstrated for the qualitative and quantitative analysis of mixtures of peptides with FAIMS
used to filter out unrelated precursor ions thereby simplifying the resulting product ion mass spectra. Liquid chromatography
combined with FISCID-MS was applied to the analysis of coeluting model peptides and tryptic peptides derived from human
plasma proteins, allowing precursor ion selection and CID to yield product ion data suitable for peptide identification via
database searching. The potential of FISCID-MS for the quantitative determination of a model peptide spiked into human
plasma in the range of 0.45−9.0 μg/mL is demonstrated, showing good reproducibility (%RSD
0.99)